Analysis of NCCN-distress thermometer in patients with ovarian cancer: results of 150 patients prior to cytoreductive ovarian cancer surgery

This analysis aimed to describe the psychological stress in patients with ovarian cancer prior to radical surgery, with a particular focus on age. The National Comperhensive Cancer Network (NCCN) Distress Thermometer (DT) was administered to 150 women undergoing surgery for ovarian cancer last week prior to surgery. We compared our data, which is a subanalysis from the “Role of Predictive Markers for Severe Postoperative Complications in Gynecological Cancer Surgery” (RISC-Gyn)-Trial with a multicenter epidemiological study as a control group, including 1913 female cancer patients from Germany. Overall, 150 patients with ovarian cancer were enrolled, of which 126 patients (82.4%) with advanced-stage disease International Federation of Gynecology and Obstetrics (FIGO III–IV), and 55 patients (37%) ≥65 years. Younger patients reported more fears, worries, and sadness and wished to be more involved in treatment decisions. Worries were three times more frequently reported by patients with a university degree. These patients had more emotional problems such as fears, worries, sadness, and nervousness than the control group. Sustainable psychological support and professional advice in school, work, and financial management could help ovarian cancer patients reduce their stress factors especially the younger women under the age 65. Empowering patients by involving them in treatment decisions seems to be one of the crucial issues we need to address in our future clinical work.

Distress; Psychological stress; Ovarian cancer; Elderly

[1] Harter P, Pfisterer J, Hilpert F, Sehouli J, Lamparter C, Kerkmann M, et al. EP869 treatment of ovarian cancer in Germany from 2004–2016: results of a nationwide quality assurance program (QS Ovar). ePoster. 2019; 29: A471.

[2] Arden-Close E, Gidron Y, Moss-Morris R. Psychological distress and its correlates in ovarian cancer: a systematic review. Psycho-Oncology. 2008; 17: 1061–72.

[3] Norton TR, Manne SL, Rubin S, Carlson J, Hernandez E, Edelson MI, et al. Prevalence and predictors of psychological distress among women with ovarian cancer. Journal of Clinical Oncology. 2004; 22: 919–926.

[4] Cassedy HF, Tucker C, Hynan LS, Phillips R, Adams C, Zimmerman MR, et al. Frequency of psychological distress in gynecologic cancer patients seen in a large urban medical center. Baylor University Medical Center Proceedings. 2018; 31: 161–164.

[5] Bodurka-Bevers D, Basen-Engquist K, Carmack CL, Fitzgerald MA, Wolf JK, de Moor C, et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecologic Oncology. 2000; 78: 302–308.

[6] Ryan H, Schofield P, Cockburn J, Butow P, Tattersall M, Turner J, et al. How to recognize and manage psychological distress in cancer patients. European Journal of Cancer Care. 2005; 14: 7–15.

[7] Goerling U, Stickel A. Quality of life in oncology. Recent Results in Cancer Research. 2014; 4: 137–152.

[8] Sehouli J, Heise K, Richter R, Woopen H, Anders L, Inci MG. Preoperative quality of life as prediction for severe postoperative complications in gynecological cancer surgery: results of a prospective study. Archives of Gynecology and Obstetrics. 2021; 303: 1057–1063.

[9] Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. The Lancet Oncology. 2009; 10: 865–871.

[10] Cohen L, Fouladi RT, Katz J. Preoperative coping strategies and distress predict postoperative pain and morphine consumption in women undergoing abdominal gynecologic surgery. Journal of Psychosomatic Research. 2005; 58: 201–209.

[11] Weis J, Brehm F, Hufeld J, Blettner G, Gruber H, Maatouk I, et al. Update of the S3 guideline “Psycho-oncological diagnostics, counseling and treatment of adult cancer patients”. Die Onkologie. 2022; 28: 812– 817. (In German)

[12] Anja Mehnert-Theuerkauf, Corinna Peterse, Uwe Koch. Empfehlungen zur Psychoonkologischen Versorgung im Akutkrankenhaus. Zeitschrift für medizinische Psychologie: ZMP. 2023; 12: 77–84. (In German)

[13] Petermann F. Hospital Anxiety and Depression Scale, Deutsche Version (HADS-D). Zeitschrift Für Psychiatrie, Psychologie Und Psychotherapie. 2011; 59: 251–253. (In German)

[14] Mehnert A, Müller D, Lehmann C, Koch U. Die deutsche version des NCCN distress-thermometers. Zeitschrift Für Psychiatrie, Psychologie Und Psychotherapie. 2006; 54: 213–223. (In German)

[15] National Comprehensive Cancer Network. NCCN Guidelines version 2.2021 Distress Management. 2021. Available at: https://www.nccn.org/docs/default-source/patient-resources/nccn_distress_thermometer.pdf (Accessed: May 2023)

[16] Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. Journal of Clinical Oncology. 2013; 31: 782–793.

[17] Inci MG, Richter R, Woopen H, Rasch J, Heise K, Anders L, et al. Role of predictive markers for severe postoperative complications in gynecological cancer surgery: a prospective study (RISC-Gyn Trial). International Journal of Gynecologic Cancer. 2020; 30: 1975–1982.

[18] Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases. 1987; 40: 373–383.

[19] Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. American Journal of Clinical Oncology. 1982; 5: 649–656.

[20] Abouleish AE, Leib ML, Cohen NH. ASA provides examples to each ASA physical status class. ASA Monitor. 2015; 79: 38–49.

[21] Mehnert A, Hartung TJ, Friedrich M, Vehling S, Brähler E, Härter M, et al. One in two cancer patients is significantly distressed: prevalence and indicators of distress. Psycho-Oncology. 2018; 27: 75–82.

[22] Colombo N, Lorusso D, Scollo P. Impact of recurrence of ovarian cancer on quality of life and outlook for the future. International Journal of Gynecologic Cancer. 2017; 27: 1134–1140.

[23] Johnson RL, Gold MA, Wyche KF. Distress in women with gynecologic cancer. Psycho-Oncology. 2010; 19: 665–668.

[24] Ploos van Amstel FK, van Ham MAPC, Peters EJ, Prins JB, Ottevanger PB. Self-reported distress in patients with ovarian cancer: is it related to disease status? International Journal of Gynecologic Cancer. 2015; 25: 229–235.

[25] Inci MG, Richter R, Heise K, Dukatz R, Woopen H, Sehouli J. Patient-reported outcomes (PROs) and health-related quality of life (HR-QoL) in patients with ovarian cancer: what is different compared to healthy women? Cancers. 2021; 13: 631.

[26] Goerling U, Mehnert A. Future research in psycho-oncology. Recent Results in Cancer Research. 2018; 24: 223–234.

[27] Weis J, Hönig K, Bergelt C, Faller H, Brechtel A, Hornemann B, et al. Psychosocial distress and utilization of professional psychological care in cancer patients: an observational study in national comprehensive cancer centers (CCCs) in Germany. Psycho-Oncology. 2018; 27: 2847–2854.

[28] Hardoerfer K, Jentschke E. Effect of yoga therapy on symptoms of anxiety in cancer patients. Oncology Research and Treatment. 2018; 41: 526–532.

[29] Lundt A, Jentschke E. Long-term changes of symptoms of anxiety, depression, and fatigue in cancer patients 6 months after the end of yoga therapy. Integrative Cancer Therapies. 2019; 18: 153473541882209.

[30] Lopez G, Chaoul A, Powers-James C, Eddy CA, Mallaiah S, Gomez TI, et al. Group yoga effects on cancer patient and caregiver symptom distress: assessment of self-reported symptoms at a comprehensive cancer center. Integrative Cancer Therapies. 2018; 17: 1087–1094.

[31] Gramaglia C, Gambaro E, Vecchi C, Licandro D, Raina G, Pisani C, et al. Outcomes of music therapy interventions in cancer patients—a review of the literature. Critical Reviews in Oncology/Hematology. 2019; 138: 241–254.

[32] Susanne Diehm, Jutta Michaud, Jalid Sehouli. Mit Schreiben zu neuer Lebenskraft: Übungsbuch für Frauen mit Krebserkrankung und ihre Angehörigen. Kösel-Verlag: Munich. 2019. (In German)

[33] Parker PA, Kudelka A, Basen-Engquist K, Kavanagh J, de Moor J, Cohen L. The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer. Gynecologic Oncology. 2006; 100: 495–500.

[34] Horsboel TA, Kjaer SK, Johansen C, Suppli NP, Ammitzbøll G, Frøding LP, et al. Increased risk for depression persists for years among women treated for gynecological cancers—a register-based cohort study with up to 19 years of follow-up. Gynecologic Oncology. 2019; 153: 625–632.

[35] Woopen H, Keller M, Braicu EI, Zocholl D, Krabisch P, Boxler T, et al. Fatigue in long-term survivors with ovarian cancer: results of expression VI—Carolin meets HANNA—holistic analysis of long-term survival with ovarian cancer—the international NOGGO, ENGOT and GCIG survey. Journal of Clinical Oncology. 2020; 38: 12065–12065.

[36] Hamilton AB. Psychological aspects of ovarian cancer. Cancer Investi-gation. 1999; 17: 335–341.

[37] Reid A, Ercolano E, Schwartz P, McCorkle R. The Management of Anxiety and Knowledge of Serum CA-125 after an ovarian cancer diagnosis. Clinical Journal of Oncology Nursing. 2011; 15: 625–632.

[38] Zimmerman MA. Psychological empowerment: issues and illustrations. American Journal of Community Psychology. 1995; 23: 581–599.

[39] Eskildsen NB, Joergensen CR, Thomsen TG, Ross L, Dietz SM, Groenvold M, et al. Patient empowerment: a systematic review of questionnaires measuring empowerment in cancer patients. Acta Oncologica. 2017; 56: 156–165.

[40] Laverack G, Pratley P. What quantitative and qualitative methods have been developed to measure community empowerment at a national level?(Report No.: 9789289053600). Copenhagen: 14 October 2018.

[41] Schneider S, Armbrust R, Spies C, du Bois A, Sehouli J. Prehabilitation programs and ERAS protocols in gynecological oncology: a comprehen-sive review. Archives of Gynecology and Obstetrics. 2020; 301: 315–326.